Human adipose-derived mesenchymal stem cells as a new model of spinal and bulbar muscular atrophy

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Dossena, Marta ^a   Bedini, Gloria ^a   Rusmini, Paola ^b   Giorgetti, Elisa ^b,c   Canazza, Alessandra ^a   Tosetti, Valentina ^a   Salsano, Ettore ^a   Sagnelli, Anna ^a   Mariotti, Caterina ^a   Gellera, Cinzia ^a   Navone, Stefania Elena ^a   Marfia, Giovanni ^a   Alessandri, Giulio ^a   Corsi, Fabio ^d   Parati, Eugenio Agostino ^a   Pareyson, Davide ^a   Poletti, Angelo ^b  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; HEAT SHOCK PROTEIN 70; MESSENGER RNA; POLYGLUTAMINE; PROTEASOME; UBIQUITIN; PEPTIDE;

ADIPOCYTE; ADIPOSE DERIVED MESENCHYMAL STEM CELL; ADIPOSE TISSUE CELL; ADULT; AGED; AMINO TERMINAL SEQUENCE; ANTIGEN EXPRESSION; ARTICLE; CARTILAGE CELL; CASE REPORT; CELL DIFFERENTIATION; CELL GROWTH; CELL ISOLATION; CELL LINEAGE; CELL SURVIVAL; CONTROLLED STUDY; DISEASE MODEL; ENZYME INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; KENNEDY DISEASE; MALE; MESENCHYMAL STEM CELL; OSTEOCYTE; PLURIPOTENT STEM CELL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; WILD TYPE; ADIPOSE TISSUE; BIOLOGICAL MODEL; CASE CONTROL STUDY; GENE EXPRESSION REGULATION; GENETICS; MESENCHYMAL STROMA CELL; METABOLISM; MIDDLE AGED; MUSCLE ATROPHY; PATHOLOGY; PRIMARY CELL CULTURE;

ADIPOCYTES; ADIPOSE TISSUE; AGED; CASE-CONTROL STUDIES; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION; HSP70 HEAT-SHOCK PROTEINS; HUMANS; MALE; MESENCHYMAL STROMAL CELLS; MIDDLE AGED; MODELS, BIOLOGICAL; MUSCULAR DISORDERS, ATROPHIC; PEPTIDES; PRIMARY CELL CULTURE; PROTEASOME ENDOPEPTIDASE COMPLEX; RECEPTORS, ANDROGEN; UBIQUITIN;

EID: 84911472522     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0112746     Document Type: Article

References (44)

1. Fischbeck KH (1997) Kennedy disease. J Inher Metab Dis 20: 152-158.
2. Jordan CL, Lieberman AP (2008) Spinal and bulbar muscular atrophy: a motoneuron or muscle disease? Curr Opin Pharmacol 8: 752-758.
3. La Spada AR, Wilson EM, Lubahn DB, Harding AE, Fischbeck KH (1991) Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 352: 77-79.
4. Poletti A (2004) The polyglutamine tract of androgen receptor: from functions to dysfunctions in motor neurons. Front Neuroendocrinol 25: 1-26.
5. Grunseich C, Kats IR, Bott LC, Rinaldi C, Kokkinis A, et al. (2014) Early onset and novel features in a spinal and bulbar muscular atrophy patient with a 68 CAG repeat. Neuromuscul Disord. 70: 12-20.
6. Poletti A, Rampoldi A, Piccioni F, Volpi S, Simeoni S, et al. (2001) 5Alpha-reductase type 2 and androgen receptor expression in gonadotropin releasing hormone GT1-1 cells. J Neuroendocrinol 13: 353-357.
7. Pozzi P, Bendotti C, Simeoni S, Piccioni F, Guerini V, et al. (2003) Androgen 5-alpha-reductase type 2 is highly expressed and active in rat spinal cord motor neurones. J Neuroendocrinol 15: 882-887.
8. Grunseich C, Rinaldi C, Fischbeck KH (2014) Spinal and bulbar muscular atrophy: pathogenesis and clinical management. Oral Dis 20: 6-9.
9. Katsuno M, Adachi H, Doyu M, Minamiyama M, Sang C, et al. (2003) Leuprorelin rescues polyglutamine-dependent phenotypes in a transgenic mouse model of spinal and bulbar muscular atrophy. Nat Med 9: 768-773.
10. Katsuno M, Adachi H, Kume A, Li M, Nakagomi Y, et al. (2002) Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy. Neuron 35: 843-854.
11. Adachi H, Kume A, Li M, Nakagomi Y, Niwa H, et al. (2001) Transgenic mice with an expanded CAG repeat controlled by the human AR promoter show polyglutamine nuclear inclusions and neuronal dysfunction without neuronal cell death. Hum Mol Genet 10: 1039-1048.
12. La Spada AR, Peterson KR, Meadows SA, McClain ME, Jeng G, et al. (1998) Androgen receptor YAC transgenic mice carrying CAG 45 alleles show trinucleotide repeat instability. Human Mol Genet 7: 959-967.
13. Sopher BL, Thomas PS Jr, LaFevre-Bernt MA, Holm IE, Wilke SA, et al. (2004) Androgen receptor YAC transgenic mice recapitulate SBMA motor neuronopathy and implicate VEGF164 in the motor neuron degeneration. Neuron 41: 687-699.
14. Abel A, Walcott J, Woods J, Duda J, Merry DE (2001) Expression of expanded repeat androgen receptor produces neurologic disease in transgenic mice. Hum Mol Genet 10: 107-116.
15. Yu Z, Dadgar N, Albertelli M, Scheller A, Albin RL, et al. (2006) Abnormalities of germ cell maturation and sertoli cell cytoskeleton in androgen receptor 113 CAG knock-in mice reveal toxic effects of the mutant protein. The American journal of pathology 168: 195-204.
16. Chevalier-Larsen ES, O'Brien CJ, Wang H, Jenkins SC, Holder L, et al. (2004) Castration restores function and neurofilament alterations of aged symptomatic males in a transgenic mouse model of spinal and bulbar muscular atrophy. J Neurosci 24: 4778-4786.
17. Cortes CJ, Ling SC, Guo LT, Hung G, Tsunemi T, et al. (2014) Muscle expression of mutant androgen receptor accounts for systemic and motor neuron disease phenotypes in spinal and bulbar muscular atrophy. Neuron 82: 295-307.
18. Rocchi A, Pennuto M (2013) New routes to therapy for spinal and bulbar muscular atrophy. J Mol Neurosci 50: 514-523.
19. Grunseich C, Zukosky K, Kats IR, Ghosh L, Harmison GG, et al. (2014) Stem cell-derived motor neurons from spinal and bulbar muscular atrophy patients. Neurobiol Dis 70: 12-20.
20. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, et al. (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147.
21. Casteilla L, Dani C (2006) Adipose tissue-derived cells: from physiology to regenerative medicine. Diabetes Metab 32: 393-401.
22. Ogura F, Wakao S, Kuroda Y, Tsuchiyama K, Bagheri M, et al. (2014) Human adipose tissue possesses a unique population of pluripotent stem cells with nontumorigenic and low telomerase activities: potential implications in regenerative medicine. Stem Cells Dev. 23: 717-728.
23. Ibrahim MM (2010) Subcutaneous and visceral adipose tissue: structural and functional differences. Obes Rev 11: 11-18.
24. Chazenbalk G, Singh P, Irge D, Shah A, Abbott DH, et al. (2013) Androgens inhibit adipogenesis during human adipose stem cell commitment to preadipocyte formation. Steroids 78: 920-926.
25. Alessandri G, Pagano S, Bez A, Benetti A, Pozzi S, et al. (2004) Isolation and culture of human muscle-derived stem cells able to differentiate into myogenic and neurogenic cell lineages. Lancet 364: 1872-1883.
26. Avanzini MA, Bernardo ME, Cometa AM, Perotti C, Zaffaroni N, et al. (2009) Generation of mesenchymal stromal cells in the presence of platelet lysate: a phenotypic and functional comparison of umbilical cord blood- and bone marrow-derived progenitors. Haematologica 94: 1649-1660.
27. Rusmini P, Crippa V, Giorgetti E, Boncoraglio A, Cristofani R, et al. (2013) Clearance of the mutant androgen receptor in motoneuronal models of spinal and bulbar muscular atrophy. Neurobiol Aging 34: 2585-2603.
28. Simeoni S, Mancini MA, Stenoien DL, Marcelli M, Weigel NL, et al. (2000) Motoneuronal cell death is not correlated with aggregate formation of androgen receptors containing an elongated polyglutamine tract. Hum Mol Genet 9: 133-144.
29. Piccioni F, Pinton P, Simeoni S, Pozzi P, Fascio U, et al. (2002) Androgen receptor with elongated polyglutamine tract forms aggregates that alter axonal trafficking and mitochondrial distribution in motor neuronal processes. Faseb J 16: 1418-1420.
30. Rusmini P, Sau D, Crippa V, Palazzolo I, Simonini F, et al. (2007) Aggregation and proteasome: the case of elongated polyglutamine aggregation in spinal and bulbar muscular atrophy. Neurobiol Aging 28: 1099-1111.
31. Huang CK, Tsai MY, Luo J, Kang HY, Lee SO, et al. (2013) Suppression of androgen receptor enhances the self-renewal of mesenchymal stem cells through elevated expression of EGFR. Biochim Biophys Acta 1833: 1222-1234.
32. Brooks BP, Merry DE, Paulson HL, Lieberman AP, Kolson DL, et al. (1998) A cell culture model for androgen effects in motor neurons. J Neurochem 70: 1054-1060.
33. Brooks BP, Paulson HL, Merry DE, Salazar-Grueso EF, Brinkmann AO, et al. (1997) Characterization of an expanded glutamine repeat androgen receptor in a neuronal cell culture system. Neurobiol Dis 3: 313-323.
34. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, et al. (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8: 315-317.
35. Bourin P, Bunnell BA, Casteilla L, Dominici M, Katz AJ, et al. (2013) Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT). Cytotherapy 15: 641-648.
36. Le Blanc K, Tammik C, Rosendahl K, Zetterberg E, Ringden O (2003) HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol 31: 890-896.
37. Tsai MY, Shyr CR, Kang HY, Chang YC, Weng PL, et al. (2011) The reduced trabecular bone mass of adult ARKO male mice results from the decreased osteogenic differentiation of bone marrow stroma cells. Biochem Biophys Res Commun 411: 477-482.
38. Chua JP, Reddy SL, Merry DE, Adachi H, Katsuno M, et al. (2014) Transcriptional activation of TFEB/ZKSCAN3 target genes underlies enhanced autophagy in spinobulbar muscular atrophy. Hum Mol Genet 23: 1376-1386.
39. Lieberman AP, Yu Z, Murray S, Peralta R, Low A, et al. (2014) Peripheral androgen receptor gene suppression rescues disease in mouse models of spinal and bulbar muscular atrophy. Cell Rep 7: 774-784.
40. Desiderio V, De Francesco F, Schiraldi C, De Rosa A, La Gatta A, et al. (2013) Human Ng2+ adipose stem cells loaded in vivo on a new crosslinked hyaluronic acid-Lys scaffold fabricate a skeletal muscle tissue. J Cell Physiol 228: 1762-1773.
41. de la Garza-Rodea AS, van der Velde-van Dijke I, Boersma H, Goncalves MA, van Bekkum DW, et al. (2012) Myogenic properties of human mesenchymal stem cells derived from three different sources. Cell Transplant 21: 153-173.
42. Marra KG, Brayfield CA, Rubin JP (2011) Adipose stem cell differentiation into smooth muscle cells. Methods Mol Biol 702: 261-268.
43. Wang C, Yin S, Cen L, Liu Q, Liu W, et al. (2010) Differentiation of adiposederived stem cells into contractile smooth muscle cells induced by transforming growth factor-beta1 and bone morphogenetic protein-4. Tissue Eng Part A 16: 1201-1213.
44. Kotaja N, Karvonen U, Janne OA, Palvimo JJ (2002) The nuclear receptor interaction domain of GRIP1 is modulated by covalent attachment of SUMO-1. J Biol Chem 277: 30283-30288.